Those who used contraceptive vaginal ring users during a 3-month period tended to report perfect use more often than oral contraceptive users, according to study findings published in March 2010 Obstetrics & Gynecology.
A 3-month study of contraceptive use among female college and graduate students found that those who used the contraceptive vaginal ring tended to report perfect use more often than those who used oral contraceptives. However, at 6-month follow-up, less than 30% of those enrolled continued to use their assigned method of birth control.
A total of 273 women were given either the vaginal ring or oral contraceptive pill and instructed to use it over a period of 3 consecutive menstrual cycles. Enrollees filled out online diaries daily to record whether they used the method that day and their satisfaction with the method of birth control during the cycles in which it was used.
At 3-month follow-up, 43% of 121 contraceptive vaginal ring users and 52% of 126 oral contraceptive users indicated they would still use that method (P=.16). At 6 months, just 26% of 117 vaginal ring users and 29% of oral contraceptive users had actually continued to use the designated method of contraception. Approximately 50% of each group reported either using condoms or nothing at all.
The study was published in Obstetrics & Gynecology (2010;115[3]:503-510).
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More